129 related articles for article (PubMed ID: 18374412)
1. Pregnancy in patients with myelodysplastic syndromes (MDS).
Volpicelli P; Latagliata R; Breccia M; Carmosino I; Stefanizzi C; Napoleone L; Vozella F; Levi A; Natalino F; Alimena G
Leuk Res; 2008 Oct; 32(10):1605-7. PubMed ID: 18374412
[TBL] [Abstract][Full Text] [Related]
2. [Hypoplastic myelodysplastic syndrome progressing to acute myelocytic leukemia (M2) after treatment with G-CSF and immunosuppressants].
Miyata A; Deguchi S; Kikuchi T; Osada T; Sanada H
Rinsho Ketsueki; 1998 Jun; 39(6):453-9. PubMed ID: 9695675
[TBL] [Abstract][Full Text] [Related]
3. [Clinical analysis of bicytopenia and pancytopenia during pregnancy].
Zhang C; Liang MY; Wang SM
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):488-91. PubMed ID: 19957545
[TBL] [Abstract][Full Text] [Related]
4. Spontaneous remission in adult patients with de novo myelodysplastic syndrome: a possible event.
Petti MC; Latagliata R; Breccia M; Alimena G; Spadea A; D'Andrea M; Mancini M; Aloe Spiriti MA; Mandelli F
Haematologica; 2001 Dec; 86(12):1277-80. PubMed ID: 11726319
[TBL] [Abstract][Full Text] [Related]
5. The spectrum of myelodysplastic syndromes post-solid organ transplantation: a single institutional experience.
Menes M; Vakiani E; Keller CE; Ho EK; Colovai A; Nichols G; Diuguid D; Mears JG; Murty VV; Alobeid B; Bhagat G
Leuk Res; 2007 Jan; 31(1):59-65. PubMed ID: 16787662
[TBL] [Abstract][Full Text] [Related]
6. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
[TBL] [Abstract][Full Text] [Related]
7. Outcome of patients with myelodysplastic syndromes: experience from a single institution in South Australia.
Hui CH; Horvath N; Lewis I; To LB; Szabo F
Intern Med J; 2008 Nov; 38(11):824-8. PubMed ID: 18284457
[TBL] [Abstract][Full Text] [Related]
8. Combination of 5-azacytidine and thalidomide for the treatment of myelodysplastic syndromes and acute myeloid leukemia.
Raza A; Mehdi M; Mumtaz M; Ali F; Lascher S; Galili N
Cancer; 2008 Oct; 113(7):1596-604. PubMed ID: 18720364
[TBL] [Abstract][Full Text] [Related]
9. Myelodysplastic syndromes during pregnancy.
Pagliuca A; Mufti GJ; Fenaux P; de Silva C; Samaratunga I
Eur J Haematol; 1991 Oct; 47(4):310-2. PubMed ID: 1954992
[No Abstract] [Full Text] [Related]
10. Latency of onset of de novo myelodysplastic syndromes.
Wu PS; Hay AE; Thomas GE; Bowen DT
Haematologica; 2004 Nov; 89(11):1392-4. PubMed ID: 15531463
[TBL] [Abstract][Full Text] [Related]
11. Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface.
Wimazal F; Fonatsch C; Thalhammer R; Schwarzinger I; Müllauer L; Sperr WR; Bennett JM; Valent P
Leuk Res; 2007 Nov; 31(11):1461-8. PubMed ID: 17507091
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplasia diagnosed during pregnancy with temporary haematological improvement after delivery.
Gidiri M; Masson EA; Ali S; Freites J; Carter C; Lindow SW
J Obstet Gynaecol; 2009 Oct; 29(7):665-7. PubMed ID: 19757280
[No Abstract] [Full Text] [Related]
13. Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
Leleu X; Soumerai J; Roccaro A; Hatjiharissi E; Hunter ZR; Manning R; Ciccarelli BT; Sacco A; Ioakimidis L; Adamia S; Moreau AS; Patterson CJ; Ghobrial IM; Treon SP
J Clin Oncol; 2009 Jan; 27(2):250-5. PubMed ID: 19064987
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies in myelodysplastic syndromes.
Atallah E; Garcia-Manero G
Cancer Invest; 2008 Mar; 26(2):208-16. PubMed ID: 18259954
[TBL] [Abstract][Full Text] [Related]
15. Secondary myelodysplastic syndrome after hydroxychloroquine therapy.
Muslimani AA; Spiro TP; Chaudhry AA; Daw HA
Ann Hematol; 2007 Jul; 86(7):531-4. PubMed ID: 17205285
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
[TBL] [Abstract][Full Text] [Related]
17. Levels of beta 2 microglobulin have a prognostic relevance for patients with myelodysplastic syndrome with regard to survival and the risk of transformation into acute myelogenous leukemia.
Neumann F; Gattermann N; Barthelmes HU; Haas R; Germing U
Leuk Res; 2009 Feb; 33(2):232-6. PubMed ID: 18639338
[TBL] [Abstract][Full Text] [Related]
18. Advanced pediatric myelodysplastic syndromes: can immunophenotypic characterization of blast cells be a diagnostic and prognostic tool?
Veltroni M; Sainati L; Zecca M; Fenu S; Tridello G; Testi AM; Merlone AD; Buldini B; Leszl A; Lo Nigro L; Longoni D; Bernini G; Basso G;
Pediatr Blood Cancer; 2009 Mar; 52(3):357-63. PubMed ID: 19061215
[TBL] [Abstract][Full Text] [Related]
19. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
[TBL] [Abstract][Full Text] [Related]
20. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]